A case of new-onset Fulminant type 1 diabetes after secondary SARS-CoV-2 infection

Jie Wang; Yiwen Huang; Feng Tao

doi:10.1016/j.heliyon.2024.e30750

A case of new-onset Fulminant type 1 diabetes after secondary SARS-CoV-2 infection

Heliyon. 2024 May 4;10(9):e30750. doi: 10.1016/j.heliyon.2024.e30750. eCollection 2024 May 15.

Authors

Jie Wang¹, Yiwen Huang¹, Feng Tao¹

Affiliation

¹ Endocrinology Department of Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071, China.

Abstract

Fulminant type 1 diabetes is a subtype of type 1 diabetes characterised by a rapid progression to diabetic ketoacidosis combined with a background of rapid and almost complete pancreatic islet destruction. FT1D induced by secondary SARS-CoV-2 infection is rare. Herein, we present the case of a 42-year-old male patient with new-onset FT1D after a secondary SARS-CoV-2 infection, with recurrent hyperglycaemia and ketosis as the primary manifestations. Eventually, the patient responded well after receiving more than 50 units of insulin daily. This case illustrates the importance of paying attention to severe hyperglycaemia accompanying recurrent ketosis, particularly among patients with secondary SARS-CoV-2 infection.

Publication types

Case Reports